A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans.

A physiologically based pharmacokinetic model which describes the behavior of inhaled styrene in rats accurately predicts the behavior of inhaled styrene in humans. The model consists of a series of mass-balance differential equations which quantify the time course of styrene concentration within four tissue groups representing (1) highly perfused organs, (2) moderately perfused tissues such as muscle, (3) slowly perfused fat tissue, and (4) organs with high capacity to metabolize styrene (principally liver). The pulmonary compartment of the model incorporates uptake of styrene controlled by ventilation and perfusion rates and the blood:air partition coefficient. The metabolizing tissue group incorporates saturable Michaelis-Menten metabolism controlled by the biochemical constants Vmax and Km. With a single set of physiological and biochemical constants, the model adequately simulates styrene concentrations in blood and fat of rats exposed to 80, 200, 600, or 1200 ppm styrene (data from previously published studies). The simulated behavior of styrene is particularly sensitive to changes in the constants describing the fat tissue group, and to the maximum metabolic rate described by Vmax. The constants used to simulate the fate of styrene in rats were scaled up to represent humans. Simulated styrene concentrations in blood and exhaled air of humans are in good agreement with previously published data. Model simulations show that styrene metabolism is saturated at inhaled concentrations above approximately 200 ppm in mice, rats, and humans. At inhaled concentrations below 200 ppm, the ratio of styrene concentration in blood to inhaled air is controlled by perfusion limited metabolism. At inhaled concentrations above 200 ppm, this ratio is controlled by the blood:air partition coefficient and is not linearly related to the ratio attained at lower (nonsaturating) exposure concentrations. These results show that physiologically based pharmacokinetic models provide a rational basis with which (1) to explain the relationship between blood concentration and air concentration of an inhaled chemical, and (2) to extrapolate this relationship from experimental animals to humans.

[1]  J. Anderson,et al.  Controlled release of tetracycline II: Development of an in vivo flow-limited pharmacokinetic model. , 1979, Journal of pharmaceutical sciences.

[2]  J. Young,et al.  PHARMACOKINETICS OF INHALED OR INTRAPERITONEALLY ADMINISTERED STYRENE IN RATS , 1979 .

[3]  H. Haggard.  THE ABSORPTION, DISTRIBUTION, AND ELIMINATION OF ETHYL ETHER III. THE RELATION OF THE CONCENTRATION OF ETHER, OR ANY SIMILAR VOLATILE SUBSTANCE, IN THE CENTRAL NERVOUS SYSTEM TO THE CONCENTRATION IN THE ARTERIAL BLOOD, AND THE BUFFER ACTION OF THE BODY , 1924 .

[4]  R L Dedrick,et al.  Species similarities in pharmacokinetics. , 1980, Federation proceedings.

[5]  Torsten Teorell,et al.  Kinetics of distribution of substances administered to the body, II : The intravascular modes of administration , 1937 .

[6]  M. Ikeda,et al.  The metabolism of styrene in the rat and the stimulatory effect of phenobarbital. , 1971, Toxicology and applied pharmacology.

[7]  R. D. Stewart,et al.  Human exposure to styrene vapor. , 1968, Archives of environmental health.

[8]  M. Rowland,et al.  In vivo evaluation of Michaelis-Menten constants of hepatic drug-eliminating systems. , 1978, Drug metabolism and disposition: the biological fate of chemicals.

[9]  J. Young,et al.  Pharmacokinetics of inhaled styrene in human volunteers. , 1980, Toxicology and applied pharmacology.

[10]  V. Fiserova-Bergerova,et al.  Predictable "individual differences" in uptake and excretion of gases and lipid soluble vapours simulation study. , 1980, British journal of industrial medicine.

[11]  E. Adolph,et al.  Quantitative Relations in the Physiological Constitutions of Mammals. , 1949, Science.

[12]  M. Gibaldi,et al.  Physiologically based pharmacokinetic model for digoxin distribution and elimination in the rat. , 1977, Journal of pharmaceutical sciences.

[13]  R. Lutz,et al.  A preliminary pharmacokinetic model for several chlorinated biphenyls in the rat. , 1977, Drug metabolism and disposition: the biological fate of chemicals.

[14]  H. Haggard,et al.  THE ABSORPTION, DISTRIBUTION, AND ELIMINATION OF ETHYL ETHER II. ANALYSIS OF THE MECHANISM OF ABSORPTION AND ELIMINATION OF SUCH A GAS OR VAPOR AS ETHYL ETHER , 1924 .

[15]  D. Holaday,et al.  Uptake and clearance of inhalation anesthetics in man. , 1979, Drug metabolism reviews.

[16]  W. Braun,et al.  Quantitative determination of styrene in biological samples and expired air by gas chromatography-mass spectrometry (selected ion monitoring). , 1978, Journal of chromatography.

[17]  W W Mapleson,et al.  Structure and quantification of a physiological model of the distribution of injected agents and inhaled anaesthetics. , 1981, British journal of anaesthesia.

[18]  J. Withey,et al.  Pharmacokinetics and distribution of styrene monomer in rats after intravenous administration. , 1977, Journal of toxicology and environmental health.

[19]  K. Bischoff,et al.  Methotrexate pharmacokinetics. , 1971, Journal of pharmaceutical sciences.

[20]  W W MAPLESON,et al.  An electric analogue for uptake and exchange of inert gases and other agents. , 1963, Journal of applied physiology.

[21]  M E Andersen,et al.  Saturable metabolism and its relationship to toxicity. , 1981, Critical reviews in toxicology.

[22]  R. Lutz,et al.  Physiological pharmacokinetics: an in vivo approach to membrane transport. , 1980, Pharmacology & therapeutics.

[23]  P. Watanabe,et al.  Resolution of dose-response toxicity data for chemicals requiring metabolic activation: example--vinyl chloride. , 1978, Toxicology and applied pharmacology.

[24]  M. Andersen,et al.  Inhalation pharmacokinetics: evaluating systemic extraction, total in vivo metabolism, and the time course of enzyme induction for inhaled styrene in rats based on arterial blood:inhaled air concentration ratios. , 1984, Toxicology and applied pharmacology.

[25]  J. Withey.  Quantitative analysis of styrene monomer in polystyrene and foods including some preliminary studies of the uptake and pharmacodynamics of the monomer in rats. , 1976, Environmental health perspectives.

[26]  A Sato,et al.  Partition coefficients of some aromatic hydrocarbons and ketones in water, blood and oil. , 1979, British journal of industrial medicine.

[27]  M E Andersen,et al.  A physiologically based toxicokinetic description of the metabolism of inhaled gases and vapors: analysis at steady state. , 1981, Toxicology and applied pharmacology.

[28]  M. Guillemin,et al.  Human exposure to styrene , 1979, International archives of occupational and environmental health.

[29]  T. Tabuchi,et al.  Evaluation of hippuric, phenylglyoxylic and mandelic acids in urine as indices of styrene exposure , 1974, Internationales Archiv fur Arbeitsmedizin.